These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9114904)

  • 21. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
    Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril.
    Ziai SA; Seyedhosseini D; Taiebi L; Salekmoghadam E; Mahmoudian M
    Acta Physiol Hung; 2000; 87(2):153-9. PubMed ID: 11205963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.
    Wyld PJ; Grant J; Lippi A; Criscuoli M; Del Re G; Subissi A
    Br J Clin Pharmacol; 1994 Nov; 38(5):421-5. PubMed ID: 7893583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Ayala N; Caballero JMS; Muñoz A
    Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration.
    Kaiser G; Ackermann R; Brechbühler S; Dieterle W
    Biopharm Drug Dispos; 1989; 10(4):365-76. PubMed ID: 2758102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.
    Waeber G; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
    Eur J Clin Pharmacol; 1987; 31(6):643-6. PubMed ID: 3030765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of age on the pharmacokinetics and pharmacodynamics of perindopril.
    Lees KR; Green ST; Reid JL
    Clin Pharmacol Ther; 1988 Oct; 44(4):418-25. PubMed ID: 2844467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril.
    Jakobsen J; Glaus L; Graf P; Degen P; Maurice NP; Bellet M; Ménard J
    J Hypertens; 1992 Sep; 10(9):1045-51. PubMed ID: 1328364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
    Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
    Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial and endocrine effects of a combination of an angiotensin converting enzyme inhibitor and a vasodilator in normotensive healthy volunteers.
    Brunel P; Guyene TT; Howald H; Ménard J
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):175-81. PubMed ID: 1717776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
    Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
    Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of acute transient exercise-induced hypertension after oral administration of four angiotensin-converting enzyme inhibitors in normotensive horses.
    Muñoz A; Esgueva M; Gómez-Díez M; Serrano-Caballero JM; Castejón-Riber C; Serrano-Rodríguez JM
    Vet J; 2016 Feb; 208():33-7. PubMed ID: 26626097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
    Tsai HH; Lees KR; Howden CW; Reid JL
    Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response studies with benazepril in mild to moderate hypertension.
    Gomez HJ
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV22-7; discussion IV51-5. PubMed ID: 1893638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
    Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
    J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
    Stockis A; De Bruyn S; Gengler C; Goethals F; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(8):554-61. PubMed ID: 13677245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term metabolic effects of the ACE-inhibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension.
    De Feo P; Torlone E; Perriello G; Fanelli C; Epifano L; Di Vincenzo A; Modarelli F; Motolese M; Brunetti P; Bolli GB
    Diabete Metab; 1992; 18(4):283-8. PubMed ID: 1459316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride.
    Kaiser G; Ackermann R; Gschwind HP; James IM; Sprengers D; McIntyre N; Defalco A; Holmes IB
    Biopharm Drug Dispos; 1990 Dec; 11(9):753-64. PubMed ID: 2271751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.